Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The ESX-5 System of Pathogenic Mycobacteria Is Involved In Capsule Integrity and Virulence through Its Substrate PPE10

LS. Ates, AD. van der Woude, J. Bestebroer, G. van Stempvoort, RJ. Musters, JJ. Garcia-Vallejo, DI. Picavet, Rv. Weerd, M. Maletta, CP. Kuijl, NN. van der Wel, W. Bitter,

. 2016 ; 12 (6) : e1005696. [pub] 20160609

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023922

Mycobacteria produce a capsule layer, which consists of glycan-like polysaccharides and a number of specific proteins. In this study, we show that, in slow-growing mycobacteria, the type VII secretion system ESX-5 plays a major role in the integrity and stability of the capsule. We have identified PPE10 as the ESX-5 substrate responsible for this effect. Mutants in esx-5 and ppe10 both have impaired capsule integrity as well as reduced surface hydrophobicity. Electron microscopy, immunoblot and flow cytometry analyses demonstrated reduced amounts of surface localized proteins and glycolipids, and morphological differences in the capsular layer. Since capsular proteins secreted by the ESX-1 system are important virulence factors, we tested the effect of the mutations that cause capsular defects on virulence mechanisms. Both esx-5 and ppe10 mutants of Mycobacterium marinum were shown to be impaired in ESX-1-dependent hemolysis. In agreement with this, the ppe10 and esx5 mutants showed reduced recruitment of ubiquitin in early macrophage infection and intermediate attenuation in zebrafish embryos. These results provide a pivotal role for the ESX-5 secretion system and its substrate PPE10, in the capsular integrity of pathogenic mycobacteria. These findings open up new roads for research on the mycobacterial capsule and its role in virulence and immune modulation.

000      
00000naa a2200000 a 4500
001      
bmc17023922
003      
CZ-PrNML
005      
20170908124946.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.ppat.1005696 $2 doi
035    __
$a (PubMed)27280885
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ates, Louis S $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. $7 gn_A_00009731
245    14
$a The ESX-5 System of Pathogenic Mycobacteria Is Involved In Capsule Integrity and Virulence through Its Substrate PPE10 / $c LS. Ates, AD. van der Woude, J. Bestebroer, G. van Stempvoort, RJ. Musters, JJ. Garcia-Vallejo, DI. Picavet, Rv. Weerd, M. Maletta, CP. Kuijl, NN. van der Wel, W. Bitter,
520    9_
$a Mycobacteria produce a capsule layer, which consists of glycan-like polysaccharides and a number of specific proteins. In this study, we show that, in slow-growing mycobacteria, the type VII secretion system ESX-5 plays a major role in the integrity and stability of the capsule. We have identified PPE10 as the ESX-5 substrate responsible for this effect. Mutants in esx-5 and ppe10 both have impaired capsule integrity as well as reduced surface hydrophobicity. Electron microscopy, immunoblot and flow cytometry analyses demonstrated reduced amounts of surface localized proteins and glycolipids, and morphological differences in the capsular layer. Since capsular proteins secreted by the ESX-1 system are important virulence factors, we tested the effect of the mutations that cause capsular defects on virulence mechanisms. Both esx-5 and ppe10 mutants of Mycobacterium marinum were shown to be impaired in ESX-1-dependent hemolysis. In agreement with this, the ppe10 and esx5 mutants showed reduced recruitment of ubiquitin in early macrophage infection and intermediate attenuation in zebrafish embryos. These results provide a pivotal role for the ESX-5 secretion system and its substrate PPE10, in the capsular integrity of pathogenic mycobacteria. These findings open up new roads for research on the mycobacterial capsule and its role in virulence and immune modulation.
650    _2
$a zvířata $7 D000818
650    _2
$a bakteriální pouzdra $x metabolismus $7 D016667
650    _2
$a buněčné linie $7 D002460
650    _2
$a chromatografie na tenké vrstvě $7 D002855
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunoblotting $7 D015151
650    _2
$a elektronová mikroskopie $7 D008854
650    _2
$a atypické mykobakteriální infekce $x metabolismus $7 D009165
650    _2
$a Mycobacterium marinum $x metabolismus $x patogenita $7 D019910
650    _2
$a sekreční systém typu VII $x metabolismus $7 D000069377
650    _2
$a virulence $x fyziologie $7 D014774
650    _2
$a faktory virulence $x metabolismus $7 D037521
650    _2
$a dánio pruhované $7 D015027
655    _2
$a časopisecké články $7 D016428
700    1_
$a van der Woude, Aniek D $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
700    1_
$a Bestebroer, Jovanka $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a van Stempvoort, Gunny $u Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
700    1_
$a Musters, René J P $u Department of Physiology and Cardiology, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a Garcia-Vallejo, Juan J $u Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a Picavet, Daisy I $u Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam the Netherlands.
700    1_
$a Weerd, Robert van de $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a Maletta, Massimiliano $u Eyen SE, Prague, Czech Republic.
700    1_
$a Kuijl, Coenraad P $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a van der Wel, Nicole N $u Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam the Netherlands.
700    1_
$a Bitter, Wilbert $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
773    0_
$w MED00008922 $t PLoS pathogens $x 1553-7374 $g Roč. 12, č. 6 (2016), s. e1005696
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27280885 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170908125548 $b ABA008
999    __
$a ok $b bmc $g 1239603 $s 984835
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 12 $c 6 $d e1005696 $e 20160609 $i 1553-7374 $m PLOS pathogens $n PLoS Pathog $x MED00008922
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...